AP-PA02
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AP-PA02, covering 2024-01-31 to 2026-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection [Phase 2]